HSP

Hospira Inc. (HSP) is recalling certain dietary supplements and anesthesia products because some may contain stainless steel particles that could restrict blood flow and lead to heart attacks or death.

Hospira said it's recalling 85 lots of its fat emulsion products Liposyn, used in infants and others who are unable to get fat in their diet, according to a press release the U.S. Food and Drug Administration posted on its Web site. The press release is from Hospira, not the FDA.

Hospira, based in Lake Forest, Ill., is also recalling certain lots of injectable propofol, which is used to sedate patients.

Hospira said it hasn't received any reports of adverse events associated with people who have taken the products, which were distributed between July and October. "Hospira is undertaking this recall in consideration of the potential for safety issues if the products are administered to patients," the company said.

The stainless steel particles got into the products via the manufacturing process and Hospira said it has corrected the problem. Anyone who experiences adverse reactions should report the issue to the FDA by phone at 1-800-FDA-1088.

-By Jared A. Favole, Dow Jones Newswires; 202.862.9207; jared.favole@dowjones.com

Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024